Acute myeloid leukemia (AML) Treatment in United Arab Emirates
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Acute Myeloid Leukemia (AML)?
AML stands for Acute Myeloid Leukemia, a blood cancer that begins in the blood and the source of the blood, bone marrow, which deals with myeloid cells responsible for the generation of red blood cells, white blood cells, and platelets. With acute myeloid leukaemia, the bone marrow produces abnormal myeloblasts, immature white blood cells that do not mature properly, thus crowding out normal cells. Therefore, a variety of symptoms and complications arise.
What is the Importance of Timely Treatment?
Preventing Disease Progression
AML is an aggressive cancer that can quickly progress if active treatment is not initiated, often leading to severe complications, organ dysfunctions, and even death.
Encourage Treatment Response
The earlier the therapy is initiated, the higher the chance of inducing remission and preventing relapse; failure to treat in time translates into poorer prognoses and decreased effectiveness of treatment.
Complications are minimised
After treating AML at its earliest possible stage, resolving the issues of these complications is much more favourable, with an increased chance of avoiding any complications that can be life-threatening.
Good long-term prognosis
If treatment is started earlier, there is a better chance of long-term survival. Although AML remains hard to cure, remission can be achieved if treatment is given aggressively after an early diagnosis.
Quality of life
An early start of management can help control a patient's symptoms like fatigue, pain, and infections, benefiting their quality of life during treatment.
What are the Common Symptoms of Acute Myeloid Leukemia (AML)?
- Fatigue and Weakness
- Pale Skin
- Frequent Infections or Fever
- Easy Bruising or Bleeding
- Swollen Lymph Nodes
- Bone or Joint Pain
- Loss of Appetite or Unexplained Weight Loss
- Shortness of Breath or Dizziness
- Abdominal Pain or Fullness
Causes and Risk Factors of Acute Myeloid Leukemia (AML)
Causes
- Genetic Mutations
- Chromosomal Abnormalities
- Infections
- Immune System Disorders
- Exposure to Radiation or Chemicals
Risk Factors
- Age
- Gender
- Family History
- Previous Cancer Treatment
- Environmental Exposures
- Genetic Syndromes
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Acute Myeloid Leukemia (AML) in the United Arab Emirates
Emerging new technologies and individualized treatment approaches significantly advanced in treating Acute Myeloid Leukemia in the United Arab Emirates. In prominent healthcare institutions, next-generation sequencing (NGS) is performed to detect mutation-specific genes, guiding the decisions for targeted therapies. Various innovations for bone marrow transplantation, including haploidentical and matched unrelated donor transplantation, improved survival rates among patients so far. The novelity of new inhibitors opened more therapeutic options for patients with relapsed or refractory AML. The immunotherapies currently being investigated in clinical trials include monoclonal antibodies and CAR-T-cell therapy.
Acute Myeloid Leukemia (AML) Prevention Tip:
Avoiding exposure to harmful chemicals
Reducing exposure to toxic substances such as benzene (produced by petrochemical industries) and cigarette smoke may reduce the likelihood of developing AML. To this end, protective equipment should be provided in high-risk workplaces.
Limiting Exposure to Radiation
There are exposures which cannot be avoided, such as treatment with radiation from a pre-existing cancer diagnosis.
Healthy Lifestyle Choices
Adopting healthy meal plans, exercising, and not smoking will significantly reduce the risk of developing AML. A strong immune system is crucial in fighting infections and diseases, including leukemia.
Genetic Counseling Services for High-Risk Individuals
Genetic counselling is an option to consider if there is a family history of leukemia or inherited conditions like Down syndrome, Fanconi anemia, or Bloom syndrome. If there is, screening and early detection can solve the issues.
Regular Health Check-Ups
These regular health check-ups will lead to early diagnosis of blood disorders. Early diagnosis of diseases such as myelodysplastic syndromes (MDS) will ensure early treatment and reduce the chances of developing AML.
Treatment options for Acute myeloid leukemia (AML)
The medical treatment for Acute Myeloid Leukemia (AML) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Chemotherapy: The induction chemotherapy regimen typically begins when a patient is given cytarabine and idarubicin. There will then be consolidation chemotherapy offered to the affected individual to get rid of residual cells and minimise the risk of relapse.
Cost Start From USD 800 - USD 6000Explore Options
Stem Cell Transplantation : Bone marrow transplants (also known as stem cell transplants) offer the possibility of a cure for some patients with high-risk or relapsed forms of acute myeloid leukemia, replacing diseased marrow with healthy cells, thus improving long-term survival chances.
{stem-cell-therapy}Targeted Therapy : Specific targeted drugs have been used to treat specific genetic mutations in the cells of patients with AML to enhance treatment benefits, particularly for those with mutations.
Cost Start From USD 5500 - USD 54000Explore Options
Immunotherapy : Emerging therapies such as immune checkpoint inhibitors (nivolumab and pembrolizumab) and CAR-T cell therapy have shown promise in using the immune system against leukemia cells for high-risk patients.
{immunotherapy}CAR-T (Chimeric Antigen Receptor T-cell) Therapy : AML is one of the most challenging conditions associated with CAR-T therapy because the antigens are not well-defined and are difficult to target. In any case, selected groups are specific for targets on the AML cell.
Cost Start From USD 200000 - USD 300000Explore Options
These are the standard diagnostic methods for diagnosing Acute Myeloid Leukemia (AML):
Imaging Studies
- CT scans or X-rays are occasionally performed if AML spreads from the bone marrow to lymph nodes or organs like the spleen or liver. Hence, they are not routinely used to diagnose AML at first.
Blood Tests
- Complete Blood Count (CBC): The initial test for AML diagnosis. It may display low levels of red blood cells, white blood cells, and platelet count. It may also show abnormal blasts, that is, immature cells in the blood.
- Peripheral Blood Smear: The blood smear under a microscope identifies the abnormality in white blood cells (blasts) characteristic of AML.
Bone Marrow Biopsy
- Bone marrow aspiration and biopsy are necessary to confirm the diagnosis. A needle is inserted through the skin into the bone (usually the hip) to extract bone marrow for analysis to look for the leukaemia cells and the percentage of blasts.
- Cytogenetic Testing: Fluorescence in situ hybridisation (FISH) and karyotyping allow the detection of chromosomal abnormalities, which may indicate specific subtypes of AML. These abnormalities will influence a treatment decision and a prognosis.
- Molecular Genetic Testing: Next-generation sequencing (NGS) allows the simultaneous analysis of multiple gene mutations affecting AML treatment.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Physical Rehabilitation
Post-treatment exercise programs improve the patients' strength, mobility, and endurance, especially after chemotherapy or stem cell transplant.
Occupational Therapy
Occupational therapists help patients restore their daily functioning activities, such as dressing and cooking. They also provide cognitive rehabilitation to help with memory and concentration issues experienced during treatment.
Psychological Support
Counselling for mental health assists patients in coping with emotional challenges like anxiety and depression during and after treatment.
Lifestyle Modifications
The nutritionist assists patients with AML experiencing problems with losing weight due to a lack of appetite and malnutrition.
Pain and Fatigue Management
Pain treatment provides symptom control through medication or alternative means against pain caused by the treatment. Features of chronic fatigue will be treated by conserving energy and regular rest to recuperate.
Instantly Connect with our Specialists
Hospitals for Acute myeloid leukemia (AML) in United Arab Emirates
Zulekha Hospital Sharjah
Sharjah, United Arab Emirates
Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
- Zulekha Hospital Sharjah is present over a 290,000 square feet area.
- The hospital stands today with a bed capacity of 185.
- The hospital also has a Cardiac Catheterization Laboratory and radiology as well as laboratory services.
- There is an ICU and Neonatal ICUs.
- There are facilities for Dialysis and advanced technological applications such as Minimal Invasive surgeries.
- In Zulekha Hospital Sharjah Bariatric procedures, Joint Replacement, Specialised Cancer Care, Cardio Thoracic and Vascular Procedure, Plastic and Reconstructive Procedure are performed.
- It also specialises in Pediatric Cardiology, Pulmonology and Chest Diseases, etc.
- Teleconsultation services as well as an international patient care center with related assistance for medical travelers are functioning in Zulekha Sharjah.
Burjeel Medical City
Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-
- Large waiting areas and consultation rooms
- Spacious lobbies on each floor
- 338 Luxurious Patient Rooms
- 70 Ambulatory Rooms
- Intensive Care Units
- The Hospital comprises various centers, under Burjeel Cancer Institute-
- Breast Center
- Uro-oncology Center
- Surface Malignancy Center (HIPC)
- Head & Oncology Center
- Medical Oncology & Hematology Center and others
Zulekha Hospital Dubai
Dubai, United Arab Emirates
Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
- The bed capacity of Zulekha Hospital Dubai is 140.
- Diagnostic centers, pharmacies, inpatient and outpatient care are provided at Zulekha Hospital Dubai.
- This hospital provides the best of healthcare packages
- Its surgical base is really strong with the hospital having successfully initiated and completed minimally invasive surgeries, joint replacement surgeries, bariatric surgeries, cardiac, and neonatal surgeries.
- Radiology, laboratory, operating theatres, dialysis section and Cardiac Catheterization Laboratory are all present in Zulekha Hospital Dubai, UAE.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose the United Arab Emirates for Acute Myeloid Leukemia?
The following are the growing reasons for the United Arab Emirates being frequented for treatment:
- Advanced Haematology Centres: Arab hospitals have world-class, modern haematology and oncology units.
- Access to Latest Treatments: Cost-effective targeted therapy, stem cell transplants, and immunotherapies.
- Highly Experienced Specialists: The United Arab Emirates employs internationally trained haematologists and oncologists who specialise in AML treatment.
- Affordable and High-Quality Care: The United Arab Emirates has lower costs than other countries, and the quality is never compromised.
- Comprehensive Patient Support: International patients receive visa assistance, travel arrangements, and multilingual medical support.
Frequently Asked Questions
While there is treatment available for AML, some patients can be cured, particularly with early detection and prompt action. The prognosis is modulated by several factors, such as age, general well-being, and the presence of any genetic mutations found in the leukemic cells.
The United Arab Emirates has advanced centres performing autologous and allogeneic stem cell transplants.
Yes, many Arab hospitals offer specialised services for international AML patients.
MRD testing helps detect tiny traces of leukemia after treatment and is widely used in the United Arab Emirates.
Hospitals offer translation services, accommodation assistance, and specialised oncology care.
The prognosis depends on the patient's age, response to treatment, presence of genetic mutations, and whether the leukemia was acute or relapsed. Younger patients with favourable mutations have better treatment results.
Treatment may cause fatigue, nausea and vomiting, hair loss, infections, low blood counts, and organ toxicity. Long-term side effects are mainly heart, lung, and immune dysfunction.
Though genetic mutations are one of the causes of AML, the vast majority of cases are not inherited. However, a family history of leukemia or other genetic syndromes can increase the risk of developing AML.
Patients are generally advised to take a high-protein, high-calorie, balanced diet, maintain good hygiene to prevent infection, and manage stress. Regular follow-up visits are essential to detect complications or relapse early.
Common complications of AML are infections, bleeding, and organ impairment owing to the low blood cell count. The significant complications, which could lead to respiratory or organ failure, are mostly experienced during intensive treatments like chemotherapy.